One-liner#

Painful urination requiring differentiation between UTI, STI, and vaginitis/urethritis—management depends on sex, age, and risk factors.

Quick nav#

Red flags / send to ED#

  • Fever + flank pain + dysuria → pyelonephritis; if septic-appearing (hypotension, tachycardia, altered), send to ED
  • Urinary retention → unable to void despite urge; needs catheterization
  • Pregnant with UTI symptoms + fever → risk of preterm labor, needs urgent evaluation
  • Immunocompromised + UTI symptoms → lower threshold for ED if any systemic symptoms

Key history#

Characterize the symptom:

  • Location: internal (urethral) vs external (vulvar irritation from urine on inflamed tissue)
  • Timing: throughout void vs at end of void (bladder spasm)
  • Duration: acute (<7 days) vs recurrent

UTI risk factors:

  • Sexual activity (new partner, frequency)
  • Prior UTIs and frequency
  • Postmenopausal (atrophic changes)
  • Diabetes, immunosuppression
  • Recent catheterization or instrumentation
  • Incomplete emptying, retention

STI risk factors:

  • New or multiple sexual partners
  • Unprotected intercourse
  • Partner with STI symptoms or diagnosis
  • Age <25 (highest chlamydia prevalence)
  • History of STIs

Associated symptoms:

  • Frequency, urgency, hematuria → bladder involvement
  • Vaginal discharge, odor, itching → vaginitis vs cervicitis
  • Urethral discharge (men) → urethritis/STI
  • Flank pain, fever, nausea → upper tract involvement
  • Suprapubic pain → cystitis

Medication review:

  • Recent antibiotics (resistance, yeast)
  • Spermicides (UTI risk)
  • New soaps, douches, hygiene products

Focused exam#

Vital signs:

  • Fever suggests upper tract or systemic infection
  • Tachycardia, hypotension → sepsis concern

Abdominal exam:

  • Suprapubic tenderness → cystitis
  • Flank/CVA tenderness → pyelonephritis

Pelvic exam (women with vaginal symptoms or unclear diagnosis):

  • External: erythema, lesions, discharge at introitus
  • Speculum: vaginal discharge (character, odor), cervical discharge/friability
  • Bimanual: cervical motion tenderness, adnexal tenderness (PID concern)

GU exam (men):

  • Urethral discharge (milk urethra if none visible)
  • Testicular tenderness, swelling → epididymitis
  • Prostate tenderness → acute prostatitis (avoid vigorous massage)

When to examine:

  • Uncomplicated cystitis in young woman with classic symptoms: exam often not needed
  • Vaginal symptoms, recurrent UTIs, unclear diagnosis, men: exam indicated

Differential (quick pattern recognition)#

Common/likely (outpatient)#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Uncomplicated cystitis“Burns when I pee,” “have to go all the time,” “just started”Acute onset, frequency, urgency, no fever, sexually active womanSuprapubic tenderness; no CVA tendernessEmpiric antibiotics; UA optional in classic presentation
Chlamydia urethritis/cervicitis“Burns a little,” “some discharge,” “my partner got tested”Young, sexually active, mild symptoms, may have dischargeMucopurulent cervical discharge; urethral discharge in menNAAT for CT/GC; treat empirically if high suspicion
Gonorrhea urethritis/cervicitis“Yellow discharge,” “really burns,” “partner has something”More symptomatic than chlamydia, purulent dischargePurulent urethral/cervical dischargeNAAT for CT/GC; treat empirically if high suspicion
Vulvovaginal candidiasis“Itchy down there,” “cottage cheese discharge,” “burns on the outside”External dysuria, pruritus, thick white discharge, recent antibioticsVulvar erythema, thick white discharge, no odorTreat empirically or confirm with wet prep/pH
Bacterial vaginosis“Fishy smell,” “grayish discharge,” “burns a little”Thin gray discharge, fishy odor (especially post-coital), external dysuriaThin gray discharge, positive whiff test, pH >4.5Wet prep; treat with metronidazole
Atrophic vaginitis“Dry down there,” “burns when I pee,” postmenopausalPostmenopausal, vaginal dryness, dyspareuniaPale, dry vaginal mucosa; petechiae; loss of rugaeVaginal estrogen
Trichomoniasis“Frothy discharge,” “smells bad,” “itchy and burning”Yellow-green frothy discharge, vulvar irritation, partner with STIStrawberry cervix (rare), frothy dischargeNAAT or wet prep; treat with metronidazole
Urethritis (non-gonococcal)“Mild burning,” “little bit of discharge”Men with mild symptoms, clear/white dischargeScant clear urethral dischargeNAAT for CT/GC; treat for NGU

Can’t-miss / urgent#

DiagnosisKeywords patients useKey cluesFocused exam cluesInitial next step
Pyelonephritis“Back pain,” “fever and chills,” “feel really sick”Fever, flank pain, nausea/vomiting, systemic symptomsCVA tenderness, fever, ill-appearingUA/culture; if stable, outpatient fluoroquinolone; if toxic, ED
PID“Pain during sex,” “lower belly pain,” “discharge”Sexually active, bilateral lower abdominal pain, feverCervical motion tenderness, adnexal tendernessNAAT, treat empirically; if severe, ED for IV antibiotics
Acute prostatitis“Can’t pee,” “fever,” “pain down there”Men, fever, perineal pain, difficulty voidingTender, boggy prostate (gentle exam); may have retentionUA/culture; fluoroquinolone 4-6 weeks; if retention/septic, ED
Epididymitis“Testicle hurts,” “swollen down there”Unilateral scrotal pain, may have dysuriaTender, swollen epididymis; positive Prehn signNAAT if <35 or STI risk; treat for STI vs enteric organisms
Herpes simplex (primary)“Blisters down there,” “really painful to pee”Severe pain, vesicles/ulcers, may have systemic symptomsVesicles, ulcers on genitalia; inguinal lymphadenopathyClinical diagnosis; confirm with PCR/culture; start antivirals

Workup#

Uncomplicated cystitis (non-pregnant woman, classic symptoms):

  • UA with or without culture acceptable
  • Many guidelines support empiric treatment without UA if classic symptoms
  • Culture if: treatment failure, recurrent UTIs, recent antibiotics, atypical symptoms

Complicated UTI (men, pregnant, catheter, anatomic abnormality, diabetes, immunocompromised):

  • UA AND urine culture with sensitivities
  • Consider BMP if concern for AKI or need to dose-adjust

Suspected STI:

  • NAAT for chlamydia and gonorrhea (urine in men; vaginal swab preferred in women, urine acceptable)
  • Consider: HIV, syphilis, hepatitis B/C if new STI diagnosis
  • Trichomonas NAAT if vaginal symptoms

Vaginitis workup:

  • Wet prep (saline and KOH) if available
  • Vaginal pH (>4.5 suggests BV or trich; <4.5 suggests yeast)
  • If no microscopy: syndromic treatment or send vaginal swab for BV/yeast/trich panel

Pyelonephritis:

  • UA and urine culture
  • BMP (assess renal function)
  • Consider CBC if diagnostic uncertainty
  • Imaging NOT routine; consider CT if: no improvement in 48-72 hours, suspected abscess, anatomic abnormality

When NOT to order:

  • Do NOT send urine culture for classic uncomplicated cystitis in young women—adds cost without changing management
  • Do NOT image for uncomplicated cystitis or pyelonephritis responding to treatment
  • Do NOT treat asymptomatic bacteriuria (except: pregnancy, pre-urologic procedure)

Initial management#

Uncomplicated cystitis:

  • Empiric antibiotics (see medication table)
  • Phenazopyridine for symptom relief (warn about orange urine)
  • Hydration encouraged

Suspected STI:

  • Treat empirically if high suspicion; don’t wait for results
  • Treat partners (expedited partner therapy where legal)
  • Counsel on abstinence until treatment complete and partners treated

Pyelonephritis (stable, non-pregnant, tolerating PO):

  • Outpatient fluoroquinolone x 7 days (or TMP-SMX x 14 days if susceptible)
  • Close follow-up in 24-48 hours
  • ED if: unable to tolerate PO, pregnant, septic, not improving

Vaginitis:

  • Treat based on diagnosis (see management by diagnosis)

Management by diagnosis#

Uncomplicated Cystitis#

Education:

  • Common infection; antibiotics work quickly (symptoms improve in 1-2 days)
  • Complete full course even if feeling better
  • Cranberry has minimal evidence but low harm if patient wants to try for prevention

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Nitrofurantoin (Macrobid)100 mg BID x 5 daysCrCl <30; avoid at term pregnancyNone$First-line; avoid if any pyelonephritis concern
TMP-SMX (Bactrim DS)1 DS tab BID x 3 daysSulfa allergy; avoid if resistance >20% locallyNone$Check local resistance patterns; avoid in 1st trimester
Fosfomycin (Monurol)3 g single doseNone significantNone$$Convenient but slightly less effective; good for resistant organisms
Ciprofloxacin250 mg BID x 3 daysTendon disorders; avoid in elderly if alternatives existNone$Reserve for resistant organisms; not first-line

Follow-up: No follow-up needed if symptoms resolve. Return if symptoms persist >48 hours or worsen.

Recurrent UTI (3 or more per year or 2 or more in 6 months)#

Education:

  • Recurrence is common; doesn’t mean something is wrong anatomically (usually)
  • Behavioral measures: post-coital voiding, adequate hydration, avoid spermicides
  • Vaginal estrogen helpful in postmenopausal women

Treatment options:

  • Post-coital prophylaxis: TMP-SMX SS or nitrofurantoin 50-100 mg after intercourse
  • Continuous prophylaxis: TMP-SMX SS daily or nitrofurantoin 50-100 mg daily x 6-12 months
  • Self-start therapy: Patient-initiated treatment at symptom onset (give prescription to keep on hand)

Follow-up: Urology referral if: anatomic abnormality suspected, persistent hematuria, not responding to prophylaxis.

Chlamydia#

Education:

  • Curable with antibiotics; partners must be treated
  • Abstain from sex for 7 days after treatment AND until partners treated
  • Reinfection common if partners not treated
  • Screen again in 3 months (high reinfection rate)

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Doxycycline100 mg BID x 7 daysPregnancyNone$Preferred; slightly more effective than azithromycin
Azithromycin1 g single doseNone significantNone$Alternative if adherence concern; less effective for rectal infection

Follow-up: Test of cure not needed unless pregnant or symptoms persist. Rescreen in 3 months.

Gonorrhea#

Education:

  • Requires injection + oral antibiotic due to resistance
  • Partners need treatment; abstain until both treated
  • Report to public health (mandatory in most states)

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Ceftriaxone500 mg IM x 1 (1 g if 150 kg or more)Severe cephalosporin allergyNone$Must give IM; always co-treat for chlamydia
PLUS Doxycycline100 mg BID x 7 daysPregnancyNone$Covers chlamydia co-infection

Follow-up: Test of cure if pharyngeal infection or symptoms persist. Rescreen in 3 months.

Trichomoniasis#

Education:

  • STI caused by parasite; partners must be treated
  • Can be asymptomatic, especially in men
  • Increases HIV transmission risk
  • Abstain from sex until both partners treated and asymptomatic

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Metronidazole500 mg BID x 7 daysAvoid alcohol x 24 hours afterNone$Preferred in women; better cure rate than single dose
Metronidazole2 g single doseAvoid alcohol x 24 hours afterNone$Alternative; preferred in men
Tinidazole2 g single doseAvoid alcohol x 72 hours afterNone$$Alternative if metronidazole fails

Follow-up: Test of cure in 3 months (high reinfection rate). Treat partners.

Vulvovaginal Candidiasis#

Education:

  • Not an STI; caused by yeast overgrowth
  • Common after antibiotics, in diabetes, with immunosuppression
  • OTC treatments work well for uncomplicated cases

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Fluconazole150 mg PO x 1Pregnancy (1st trimester); drug interactionsLFTs if recurrent use$Most convenient; avoid in pregnancy
Miconazole 2% creamIntravaginal daily x 7 daysNoneNone$OTC; safe in pregnancy
Clotrimazole 1% creamIntravaginal daily x 7 daysNoneNone$OTC; safe in pregnancy

Recurrent candidiasis (4 or more episodes per year):

  • Fluconazole 150 mg every 72 hours x 3 doses, then weekly x 6 months
  • Check HbA1c to rule out diabetes
  • Consider HIV testing if not recently done

Follow-up: None needed if symptoms resolve. Return if recurrent.

Bacterial Vaginosis#

Education:

  • Not an STI but associated with sexual activity
  • Caused by imbalance in vaginal bacteria
  • Recurrence common (30% within 3 months)
  • Avoid douching

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Metronidazole500 mg PO BID x 7 daysAvoid alcohol (disulfiram reaction)None$First-line; warn about alcohol
Metronidazole gel 0.75%5 g intravaginally daily x 5 daysNoneNone$$Alternative; less GI side effects
Clindamycin cream 2%5 g intravaginally at bedtime x 7 daysNoneNone$$Alternative; may weaken condoms

Follow-up: None needed if symptoms resolve. No need to treat male partners.

Pyelonephritis (Outpatient Management)#

Education:

  • Kidney infection; more serious than bladder infection
  • Must complete full antibiotic course
  • Should feel better in 24-48 hours; if not, need reassessment
  • Stay hydrated; rest

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Ciprofloxacin500 mg BID x 7 daysTendon disordersNone$First-line if local resistance <10%
Levofloxacin750 mg daily x 5 daysTendon disordersNone$Alternative fluoroquinolone
TMP-SMX DS1 tab BID x 14 daysSulfa allergyNone$Use if culture shows susceptibility

Criteria for outpatient treatment:

  • Non-pregnant
  • Tolerating oral intake
  • No sepsis criteria
  • Reliable follow-up
  • No urinary obstruction

Follow-up: Phone or visit in 24-48 hours. If not improving, reassess (may need imaging, IV antibiotics).

UTI in Pregnancy#

Education:

  • UTIs more common and more serious in pregnancy
  • Asymptomatic bacteriuria MUST be treated (unlike non-pregnant patients)
  • Untreated UTI increases risk of pyelonephritis and preterm labor
  • Some antibiotics are contraindicated

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Nitrofurantoin (Macrobid)100 mg BID x 5-7 daysAvoid at term (38+ weeks); G6PD deficiencyNone$Safe in 2nd/3rd trimester; avoid near delivery
Cephalexin500 mg BID x 7 daysCephalosporin allergyNone$Safe throughout pregnancy
Amoxicillin-clavulanate500 mg BID x 7 daysPenicillin allergyNone$Safe throughout pregnancy
Fosfomycin3 g single doseNoneNone$$Safe in pregnancy; good for resistant organisms

Avoid in pregnancy:

  • TMP-SMX (1st trimester: neural tube defects; 3rd trimester: kernicterus)
  • Fluoroquinolones (cartilage toxicity)
  • Nitrofurantoin at term (hemolytic anemia in newborn)

Follow-up: Test of cure 1-2 weeks after treatment. Monthly urine cultures for remainder of pregnancy if history of UTI.

Male UTI (Complicated by Definition)#

Education:

  • UTIs in men are uncommon and always considered complicated
  • Often associated with anatomic abnormality, BPH, or recent instrumentation
  • Longer treatment course required
  • May need urology evaluation

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Ciprofloxacin500 mg BID x 7 daysTendon disordersNone$First-line; good prostate penetration
Levofloxacin500 mg daily x 7 daysTendon disordersNone$Alternative fluoroquinolone
TMP-SMX DS1 tab BID x 7-14 daysSulfa allergyNone$Use if culture shows susceptibility

Workup:

  • Always send urine culture
  • Consider post-void residual if BPH suspected
  • Urology referral if: recurrent UTIs, anatomic abnormality suspected, not responding to treatment

Follow-up: Repeat culture after treatment to confirm clearance. Urology referral for recurrent infections.

Atrophic Vaginitis#

Education:

  • Due to low estrogen after menopause
  • Vaginal estrogen is safe and effective (minimal systemic absorption)
  • Takes 4-6 weeks to see full benefit
  • Can use long-term

Treatment:

DrugDoseContraindicationsMonitoringCostNotes
Estradiol vaginal cream0.5-1 g intravaginally 2-3x/weekUnexplained vaginal bleeding; breast cancer (relative)None$$Most studied; use applicator
Estradiol vaginal tablet (Vagifem)10 mcg intravaginally 2x/weekSame as aboveNone$$Less messy than cream
Estradiol vaginal ring (Estring)Insert every 90 daysSame as aboveNone$$$Most convenient; patient inserts
Ospemifene (Osphena)60 mg PO dailyVTE history; breast cancerNone$$$$Oral option; SERM

Follow-up: 4-6 weeks to assess response. Continue indefinitely if effective.

Follow-up#

Uncomplicated cystitis:

  • No routine follow-up needed
  • Return if symptoms persist >48 hours or recur within 2 weeks

Pyelonephritis:

  • Phone check in 24-48 hours
  • If not improving: office visit, consider imaging, possible hospitalization

STIs:

  • Rescreen in 3 months for chlamydia/gonorrhea (high reinfection rate)
  • Ensure partners treated

Recurrent UTIs:

  • Follow-up in 1-3 months on prophylaxis
  • Urology referral if not responding to prophylaxis or red flags present

Return precautions (all patients):

  • Fever, chills, flank pain (suggests upper tract infection)
  • Unable to keep fluids/medications down
  • Symptoms worsening despite treatment
  • Blood in urine (if not already present)

Patient instructions#

  • Take all your antibiotic doses, even if you feel better before finishing
  • Drink plenty of water to help flush out the infection
  • You can take phenazopyridine (AZO) for pain—it turns your urine bright orange, which is normal
  • Avoid sex until you finish treatment (and your partner is treated, if applicable)
  • Call or return if: fever, back pain, vomiting, symptoms getting worse, or not improving after 2 days
  • To help prevent future infections: urinate after sex, wipe front to back, stay hydrated

Smartphrase snippets#

Uncomplicated cystitis: “Symptoms and UA consistent with uncomplicated urinary tract infection. No red flags for upper tract involvement. Treated with [antibiotic] x [duration]. Return precautions given for fever, flank pain, or worsening symptoms.”

STI treatment: “NAAT sent for CT/GC. Given clinical suspicion, treated empirically with [regimen]. Partner treatment discussed; expedited partner therapy provided. Advised abstinence x 7 days. Will rescreen in 3 months.”

Pyelonephritis (outpatient): “Presentation consistent with acute pyelonephritis—fever, CVA tenderness, pyuria. Patient is hemodynamically stable, tolerating PO, and has reliable follow-up. Treated with [fluoroquinolone] x 7 days. Urine culture pending. Phone follow-up in 24-48 hours; return immediately if worsening or unable to tolerate PO.”